Brightpoint, Inc. (Nasdaq: CELL) announced that its Board has voted to terminate the Company's shareholders rights plan, or "poison pill ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE